Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: NOVOTECH DRUG DEVELOPMENT CONSULTING LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2020-06-25 to 2021-06-24
Current total value of award: $78955.5
Description: THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE REMAINING EXPIRING FISCAL YEAR FUNDING BY $12,044.50 FROM $91,000.00 TO $78,955.50.